Pertussis is an endemic disease in the EU/EEA and worldwide. Every three to five years, larger epidemics are expected even with high vaccination coverage.
In 2019, the hajj will take place between 9 and 14 August. The risk for EU/EEA citizens to become infected with communicable diseases during the 2019 hajj is considered low, thanks to the vaccination requirements for travelling to Makkah (Mecca) and the Saudi Arabian preparedness plans that address the management of health hazards during and after hajj.
Since 23 August 2017 Madagascar has been experiencing an outbreak of plague, and as of 3 October 2017, 194 cases and 30 deaths (case fatality rate 15.5%) have been reported.
Madagascar has been experiencing an outbreak of plague since 23 August 2017, and 560 cases and 57 deaths (case fatality rate 10.1%) have been reported as of 12 October 2017.
Illnesses caused by infectious diseases are common in children in schools or other childcare settings. Currently there is no common EU approach to the control of communicable diseases in schools or other childcare settings, and existing information is uncertain.
This document assesses the risk to human health posed by a multi-country foodborne outbreak of Shiga toxin-producing Escherichia coli (STEC) infections associated with haemolytic uraemic syndrome taking place in the European Union (EU).
This Rapid Risk Assessment focuses on acellular pertussis-containing combination vaccines used in national vaccination programmes in the EU/EEA Member States.
Early in 2015, a shortage of acellular pertussis-containing vaccines was brought to the attention of ECDC. This risk assessment provides a detailed list of mitigation options available to Member States.
This document is an update of the EFSA/ECDC joint rapid risk assessment of 29 June and aims to add new information to this and earlier initial rapid risk assessments (27 May and 14 June 2011).